Raben David's Form 4 filing
Bicara Therapeutics Inc. (BCAX) · filed Nov 25, 2025
- Accession no.
- 0002034679-25-000006
- Filed
- Nov 25, 2025
- Trade date
- Nov 24-25, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $205.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raben DavidCIK 0002034679 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Common Stock | MOption exerciseAcquired | +5,500 | $3.79 | +$20,845 | 40,997 | Direct | |
| Nov 24, 2025 | Common Stock | SSaleDisposed | −5,500 | $18.45 | −$101,475 | 35,497 | Direct | |
| Nov 25, 2025 | Common Stock | MOption exerciseAcquired | +4,594 | $3.79 | +$17,411.26 | 40,091 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −4,594 | $18.84 | −$86,550.96 | 35,497 | Direct | |
| Nov 25, 2025 | Common Stock | MOption exerciseAcquired | +906 | $3.79 | +$3,433.74 | 36,403 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −906 | $18.84 | −$17,069.04 | 35,497 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Common Stock | MOption exerciseDisposed | −5,500 | $0.00 | $0 | 123,370 | Direct | |
| Nov 25, 2025 | Common Stock | MOption exerciseDisposed | −4,594 | $0.00 | $0 | 118,776 | Direct | |
| Nov 25, 2025 | Common Stock | MOption exerciseDisposed | −906 | $0.00 | $0 | 69,413 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.